116 related articles for article (PubMed ID: 11432715)
1. Interval cancers in a French breast cancer-screening programme (Somme Department).
Ganry OF; Peng J; Raverdy NL; Dubreuil AR
Eur J Cancer Prev; 2001 Jun; 10(3):269-74. PubMed ID: 11432715
[TBL] [Abstract][Full Text] [Related]
2. Analysis and classification of interval cancers in a French breast cancer screening programme (département of Isère).
Exbrayat C; Garnier A; Colonna M; Assouline D; Salicru B; Winckel P; Menegoz F; Bolla M
Eur J Cancer Prev; 1999 Jul; 8(3):255-60. PubMed ID: 10443955
[TBL] [Abstract][Full Text] [Related]
3. Interval cancers in the Dutch breast cancer screening programme.
Fracheboud J; de Koning HJ; Beemsterboer PM; Boer R; Verbeek AL; Hendriks JH; van Ineveld BM; Broeders MJ; de Bruyn AE; van der Maas PJ
Br J Cancer; 1999 Nov; 81(5):912-7. PubMed ID: 10555768
[TBL] [Abstract][Full Text] [Related]
4. A breast cancer screening programme operating in a liberal health care system: the Luxembourg Mammography Programme, 1992-1997.
Autier P; Shannoun F; Scharpantgen A; Lux C; Back C; Severi G; Steil S; Hansen-Koenig D
Int J Cancer; 2002 Feb; 97(6):828-32. PubMed ID: 11857363
[TBL] [Abstract][Full Text] [Related]
5. Natural history of breast cancers detected in the Swedish mammography screening programme: a cohort study.
Zahl PH; Gøtzsche PC; Mæhlen J
Lancet Oncol; 2011 Nov; 12(12):1118-24. PubMed ID: 21996169
[TBL] [Abstract][Full Text] [Related]
6. Breast cancer incidence: Decreasing trend in large tumours in women aged 50-74.
Molinié F; Delacour-Billon S; Tretarre B; Delafosse P; Seradour B; Colonna M
J Med Screen; 2017 Dec; 24(4):189-194. PubMed ID: 27810986
[TBL] [Abstract][Full Text] [Related]
7. Mammography screening for breast cancer in Copenhagen April 1991-March 1997. Mammography Screening Evaluation Group.
Lynge E
APMIS Suppl; 1998; 83():1-44. PubMed ID: 9850674
[TBL] [Abstract][Full Text] [Related]
8. Aggressive primary treatments with favourable 5-year survival for screen-interval breast cancers.
Defossez G; Quillet A; Ingrand P
BMC Cancer; 2018 Apr; 18(1):393. PubMed ID: 29625602
[TBL] [Abstract][Full Text] [Related]
9. Interval breast cancers in the Screening Mammography Program of British Columbia: analysis and classification.
Burhenne HJ; Burhenne LW; Goldberg F; Hislop TG; Worth AJ; Rebbeck PM; Kan L
AJR Am J Roentgenol; 1994 May; 162(5):1067-71; discussion 1072-5. PubMed ID: 8165983
[TBL] [Abstract][Full Text] [Related]
10. [Contributions of the epidemiological cancer registries to the evaluation of mammography screening in Germany].
Urbschat I; Kieschke J; Schlanstedt-Jahn U; von Gehlen S; Thiel A; Jensch P
Gesundheitswesen; 2005 Jul; 67(7):448-54. PubMed ID: 16103967
[TBL] [Abstract][Full Text] [Related]
11. Mammography screening in the county of Fyn. November 1993-December 1999.
Njor SH; Olsen AH; Bellstrøm T; Dyreborg U; Bak M; Axelsson C; Graversen HP; Schwartz W; Lynge E
APMIS Suppl; 2003; (110):1-33. PubMed ID: 12739252
[TBL] [Abstract][Full Text] [Related]
12. Interval cancer rates in the Irish national breast screening programme.
O'Brien KM; Dwane F; Kelleher T; Sharp L; Comber H
J Med Screen; 2015 Sep; 22(3):136-43. PubMed ID: 25917389
[TBL] [Abstract][Full Text] [Related]
13. Evidence of the effect of adjunct ultrasound screening in women with mammography-negative dense breasts: interval breast cancers at 1 year follow-up.
Corsetti V; Houssami N; Ghirardi M; Ferrari A; Speziani M; Bellarosa S; Remida G; Gasparotti C; Galligioni E; Ciatto S
Eur J Cancer; 2011 May; 47(7):1021-6. PubMed ID: 21211962
[TBL] [Abstract][Full Text] [Related]
14. Results from 10 years of breast screening in Wales.
Fielder H; Rogers C; Gower-Thomas K; Monypenny I; Dallimore N; Brook D; Greening S
J Med Screen; 2001; 8(1):21-3. PubMed ID: 11373845
[TBL] [Abstract][Full Text] [Related]
15. Trends in breast cancer stage distribution before, during and after introduction of a screening programme in Norway.
Lousdal ML; Kristiansen IS; Møller B; Støvring H
Eur J Public Health; 2014 Dec; 24(6):1017-22. PubMed ID: 24596400
[TBL] [Abstract][Full Text] [Related]
16. Impact of screening on breast cancer detection. Retrospective comparative study of two periods ten years apart.
Aubard Y; Genet D; Eyraud JL; Clavère P; Tubiana-Mathieu N; Philippe HJ
Eur J Gynaecol Oncol; 2002; 23(1):37-41. PubMed ID: 11876389
[TBL] [Abstract][Full Text] [Related]
17. A pooled analysis of interval cancer rates in six European countries.
Törnberg S; Kemetli L; Ascunce N; Hofvind S; Anttila A; Sèradour B; Paci E; Guldenfels C; Azavedo E; Frigerio A; Rodrigues V; Ponti A
Eur J Cancer Prev; 2010 Mar; 19(2):87-93. PubMed ID: 20010429
[TBL] [Abstract][Full Text] [Related]
18. Breast cancer yield for screening mammographic examinations with recommendation for short-interval follow-up.
Kerlikowske K; Smith-Bindman R; Abraham LA; Lehman CD; Yankaskas BC; Ballard-Barbash R; Barlow WE; Voeks JH; Geller BM; Carney PA; Sickles EA
Radiology; 2005 Mar; 234(3):684-92. PubMed ID: 15734926
[TBL] [Abstract][Full Text] [Related]
19. Delayed diagnosis of breast cancer in women recalled for suspicious screening mammography.
Duijm LE; Groenewoud JH; de Koning HJ; Coebergh JW; van Beek M; Hooijen MJ; van de Poll-Franse LV
Eur J Cancer; 2009 Mar; 45(5):774-81. PubMed ID: 19046632
[TBL] [Abstract][Full Text] [Related]
20. [Nationwide breast cancer screening fully accomplished; results from the implementation phase 1990-1997. National Evaluation Team for Breast Cancer Screening].
Ned Tijdschr Geneeskd; 2000 Jun; 144(23):1124-9. PubMed ID: 10876708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
